Effect of continuous saline bladder irrigation with concomitant single instillation of chemotherapy after transurethral resection on intravesical recurrence in patients with non-muscle-invasive bladder cancer

被引:5
|
作者
Kuroda, Kenji [1 ]
Tasaki, Shinsuke [1 ]
Sato, Akinori [1 ]
Asakuma, Junichi [1 ]
Horiguchi, Akio [1 ]
Ito, Keiichi [1 ]
机构
[1] Natl Def Med Coll, Dept Urol, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan
关键词
bladder cancer; continuous saline bladder irrigation; non-muscle-invasive bladder cancer; intravesical recurrence; IMMEDIATE POSTOPERATIVE INSTILLATION; PROGRESSION; GUIDELINES; RISK;
D O I
10.3892/mco.2020.2079
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A single immediate instillation of chemotherapy following transurethral resection of bladder tumor (TURBT) is effective in preventing intravesical recurrence (IVR) in patients with non-muscle-invasive urothelial bladder carcinoma (NMIBC). However, continuous saline bladder irrigation (CSBI) is also performed with a single instillation of chemotherapy (SIC), but its inhibitory effect on IVR remains unclear. In the present study, the effect of CSBI with concomitant SIC following TUR on IVR was evaluated in patients with NMIBC. A retrospective review of 253 patients who underwent TURBT and were clinically and histologically diagnosed with NMIBC at National Defense Medical College Hospital was performed. Doxorubicin (DXR) was administered to all patients. Methods of DXR administration included a single instillation of DXR (60 mg in 30-40 ml saline) in 34 patients (group A), continuous irrigation of the bladder with saline including DXR (80 mg in 1 liter saline) in 40 patients (group B) and overnight CSBI after a single instillation of DXR in 179 patients (group C). The difference in IVR-free survival rates was compared after adjusting for significant differences in several covariates between the groups by nearest-neighbor propensity score matching. Prior to propensity score matching, it was identified that time to IVR was significantly longer in group A than in groups B and C; however, it was observed that several factors significantly differed among the three groups. By using nearest neighbor matching, 18 pairs were matched between groups A and B and 33 pairs between the groups A and C. No significant difference was identified in any covariates between these two matched group pairsTime to IVR was significantly longer in the matched group A than in the matched groups B and C (P=0.0255 and P=0.0023, respectively). In conclusion, SIC alone could provide a higher IVR-free survival rate than CSBI with DXR or CSBI with SIC.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [31] Surgical checklist impact on recurrence-free survival of patients with non-muscle-invasive bladder cancer undergoing transurethral resection of bladder tumour
    Suarez-Ibarrola, Rodrigo
    Soria, Francesco
    Abufaraj, Mohammad
    D'Andrea, David
    Preto, Mirko
    Gust, Kilian M.
    Briganti, Alberto
    Shariat, Shahrokh F.
    Gontero, Paolo
    BJU INTERNATIONAL, 2019, 123 (04) : 646 - 650
  • [32] Transurethral resection combined with gemcitabine intravesical instillation in the treatment of non-muscle invasive bladder cancer in the elderly
    Long, Hao
    Kong, Xiangjun
    Pei, Lijun
    Deng, Qingfu
    Zeng, Yang
    Li, Xiong
    Jiang, Rui
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (09): : 6877 - 6885
  • [33] Bladder intracavitary hyperthermic perfusion chemotherapy for the prevention of recurrence of non-muscle invasive bladder cancer after transurethral resection
    Ba, Mingchen
    Cui, Shuzhong
    Wang, Bin
    Long, Hui
    Yan, Zhaofei
    Wang, Shuai
    Wu, Yinbing
    Gong, Yuanfeng
    ONCOLOGY REPORTS, 2017, 37 (05) : 2761 - 2770
  • [34] Intra-arterial chemotherapy combined with intravesical chemotherapy compared with intravesical BCG immunotherapy retrospectively in high-risk non-muscle-invasive bladder cancer after transurethral resection of the bladder tumor
    Huang, Bin
    Huang, Gaowei
    Li, Wenji
    Chen, Lingwu
    Mao, Xiaopeng
    Chen, Junxing
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (06) : 1781 - 1788
  • [35] Single monthly bacillus Calmette-Gu,rin intravesical instillation is effective maintenance therapy to prevent recurrence in Japanese patients with non-muscle-invasive bladder cancer
    Okamura, Takehiko
    Akita, Hidetoshi
    Ando, Ryosuke
    Ikegami, Yosuke
    Naiki, Taku
    Kawai, Noriyasu
    Tozawa, Keiichi
    Kohri, Kenjiro
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2012, 17 (05) : 477 - 481
  • [36] The value of transurethral thulium laser en bloc resection combined with a single immediate postoperative intravesical instillation of pirarubicin in primary non-muscle-invasive bladder cancer
    Sheng Xu
    Shaoying Tan
    Tingming Wu
    Jun Gu
    Lei Xu
    Xianping Che
    Lasers in Medical Science, 2020, 35 : 1695 - 1701
  • [37] Should All Patients with Non-Muscle-Invasive Bladder Cancer Receive Early Intravesical Chemotherapy after Transurethral Resection? The Results of a Prospective Randomised Multicentre Study
    Gudjonsson, Sigurdur
    Adell, Lars
    Merdasa, Fekadu
    Olsson, Ronnie
    Larsson, Bruno
    Davidsson, Thomas
    Richthofff, Jonas
    Hagberg, Gunnar
    Grabe, Magnus
    Bendahl, Par Ola
    Mansson, Wiking
    Liedberg, Fredrik
    EUROPEAN UROLOGY, 2009, 55 (04) : 773 - 780
  • [38] Expression profile of E-cadherin and N-cadherin in non-muscle-invasive bladder cancer as a novel predictor of intravesical recurrence following transurethral resection
    Muramaki, Mototsugu
    Miyake, Hideaki
    Terakawa, Tomoaki
    Kumano, Masafumi
    Sakai, Iori
    Fujisawa, Masato
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2012, 30 (02) : 161 - 166
  • [39] Results of a prospective randomized study assessing the efficacy of fluorescent cystoscopy-assisted transurethral resection and single instillation of doxorubicin in patients with non-muscle-invasive bladder cancer
    Rolevich, Alexander I.
    Zhegalik, Alexander G.
    Mokhort, Andrey A.
    Minich, Alexander A.
    Vasilevich, Vladimir Yu.
    Polyakov, Sergey L.
    Krasny, Sergey A.
    Sukonko, Oleg G.
    WORLD JOURNAL OF UROLOGY, 2017, 35 (05) : 745 - 752
  • [40] Developments in intravesical therapy for non-muscle-invasive bladder cancer
    Lammers, Rianne J. M.
    Witjes, J. Alfred
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (12) : 1903 - 1916